R Squared’s AbbVie ABBV Stock Holding History

R Squared’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,516	Closed	-$351K	–	514
2025 Q3	$351K	Sell	1,516 -8,860	-85%	-$1.8M	0.15%	220
2025 Q2	$1.93M	Buy	10,376 +9,266	+835%	+$1.72M	1.06%	10
2025 Q1	$233K	Buy	1,110 +1,040	+1,486%	+$202K	0.25%	175
2024 Q4	$12.4K	Buy	+70	New	+$12.9K	0.01%	1079

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

R Squared's ABBV Position: Q4 2025 in Review

R Squared sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,516 shares — an estimated $351K sold.

R Squared first reported a position in ABBV in Q4 2024 and held it in 4 quarters. The position peaked at $1.93M in Q2 2025. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

R Squared reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
R Squared sold 1,516 AbbVie shares in Q4 2025, an estimated $351K.
R Squared first reported a position in AbbVie in Q4 2024 and held it in 4 quarters.
R Squared's AbbVie position peaked at $1.93M in Q2 2025.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.